{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-29",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Hauppauge",
      "state": "NY",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "90551",
      "recalling_firm": "Loud Muscle Science",
      "address_1": "300 Oser Ave",
      "address_2": "N/A",
      "postal_code": "11788-3608",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Press Release",
      "distribution_pattern": "The product was distributed nationwide in the USA and Canada.",
      "recall_number": "D-1340-2022",
      "product_description": "Launch Sequence Euphoria Capsules, 10- count tins, ASIN B08ZJX4V9J, UPC Code 661020846864.",
      "product_quantity": "1500 10-count tins",
      "reason_for_recall": "Marketed Without An Approved NDA/ANDA: Unapproved Drug based on label claims.",
      "recall_initiation_date": "20220627",
      "center_classification_date": "20220815",
      "termination_date": "20230208",
      "report_date": "20220727",
      "code_info": "Lot# C07172101, Exp date: 07/2024."
    }
  ]
}